Format

Send to

Choose Destination
J Neurosci. 2015 Sep 2;35(35):12241-7. doi: 10.1523/JNEUROSCI.3937-14.2015.

Oligodendrocyte Regeneration and CNS Remyelination Require TACE/ADAM17.

Author information

1
Department of Pharmacological Sciences, Centers for Molecular Medicine, Stony Brook University, SUNY, Stony Brook, New York 11794, Adan.Aguirre@StonyBrook.edu Javier.PalazuelosDiego@StonyBrook.edu.
2
Department of Pharmacological Sciences, Centers for Molecular Medicine, Stony Brook University, SUNY, Stony Brook, New York 11794.
3
Department of Pathology, University of Washington, Seattle, Washington 98195, and.
4
Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan 48109.

Abstract

The identification of the molecular network that supports oligodendrocyte (OL) regeneration under demyelinating conditions has been a primary goal for regenerative medicine in demyelinating disorders. We recently described an essential function for TACE/ADAM17 in regulating oligodendrogenesis during postnatal myelination, but it is unknown whether this protein also plays a role in OL regeneration and remyelination under demyelinating conditions. By using genetic mouse models to achieve selective gain- or loss-of-function of TACE or EGFR in OL lineage cells in vivo, we found that TACE is critical for EGFR activation in OLs following demyelination, and therefore, for sustaining OL regeneration and CNS remyelination. TACE deficiency in oligodendrocyte progenitor cells following demyelination disturbs OL lineage cell expansion and survival, leading to a delay in the remyelination process. EGFR overexpression in TACE deficient OLs in vivo restores OL development and postnatal CNS myelination, but also OL regeneration and CNS remyelination following demyelination. Our study reveals an essential function of TACE in supporting OL regeneration and CNS remyelination that may contribute to the design of new strategies for therapeutic intervention in demyelinating disorders by promoting oligodendrocyte regeneration and myelin repair.

SIGNIFICANCE STATEMENT:

Oligodendrocyte (OL) regeneration has emerged as a promising new approach for the treatment of demyelinating disorders. By using genetic mouse models to selectively delete TACE expression in oligodendrocyte progenitors cells (OPs), we found that TACE/ADAM17 is required for supporting OL regeneration following demyelination. TACE genetic depletion in OPs abrogates EGFR activation in OL lineage cells, and perturbs cell expansion and survival, blunting the process of CNS remyelination. Moreover, EGFR overexpression in TACE-deficient OPs in vivo overcomes the defects in OL development during postnatal development but also OL regeneration during CNS remyelination. Our study identifies TACE as an essential player in OL regeneration that may provide new insights in the development of new strategies for promoting myelin repair in demyelinating disorders.

KEYWORDS:

ADAM17; EGFR; TACE; oligodendrocyte precursor; remyelination

PMID:
26338334
PMCID:
PMC4556789
DOI:
10.1523/JNEUROSCI.3937-14.2015
[Indexed for MEDLINE]
Free PMC Article

Publication types, MeSH terms, Substances, Grant support

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center